Prophylaxis for patients at Risk to Eliminate Post-operative Atrial Fibrillation (PREP-AF trial): a protocol for a feasibility randomized controlled study.

Trials
Heather A SmithAndrew J E Seely

Abstract

Postoperative atrial fibrillation (POAF) is a frequent adverse event after thoracic surgery with associated morbidity, mortality, and healthcare costs. It has been shown to be preventable with prophylactic amiodarone, which is only recommended in high-risk individuals due to the potential associated side effects. Risk factors for POAF have been identified and incorporated into a prediction model to identify high-risk patients. Further evaluation in the form of a multicenter clinical trial is required to assess the effectiveness of prophylaxis specifically in this high-risk population. The feasibility of such a trial first needs to be assessed. The PREP-AF trial is a double-blind randomized controlled feasibility trial. Individuals undergoing major thoracic surgery who are identified to be high-risk by the POAF prediction model will be randomized 1:1 to receive a short course of amiodarone vs. placebo in the immediate postoperative period. The primary outcome is feasibility, which will be measured by the number of eligible patients identified, consented, and randomized; intervention adherence; and measurement of future outcomes of a full trial. This study will determine the feasibility of a randomized controlled trial to assess ...Continue Reading

References

Jan 1, 1986·Journal of the American College of Cardiology·V TorresJ C Somberg
Jun 1, 1994·Chest·W Van MieghemM G Demedts
Apr 28, 2005·The Annals of Thoracic Surgery·Rod S PassmanValerie W Rusch
Jun 16, 2009·British Journal of Clinical Pharmacology·Heleen van der SijsTeun van Gelder
Aug 25, 2009·The Annals of Thoracic Surgery·James E TisdaleKenneth A Kesler
Apr 13, 2010·The Journal of Thoracic and Cardiovascular Surgery·James E TisdaleKenneth A Kesler
Aug 25, 2010·The Annals of Thoracic Surgery·Andrew J E SeelyR Sudhir Sundaresan
Mar 7, 2012·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Vinay P RaoJohn P Duffy
Apr 21, 2012·The Annals of Thoracic Surgery·Lars P RiberHans K Pilegaard
Jan 19, 2016·Journal of Cardiovascular Pharmacology·Liangze Zhang, Shugeng Gao
May 24, 2016·Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC·James E Tisdale
Mar 12, 2019·The Journal of Thoracic and Cardiovascular Surgery·James E TisdaleKenneth A Kesler

❮ Previous
Next ❯

Software Mentioned

R
TOHAMO

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.